Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy

Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. With this type of therapy, some of the patient’s own (autologous) stem cells are removed at a convenient time and generally re-implanted after a course of high-dose chemotherapy. At present, there is neither indication nor proof of additional benefit compared to conventional chemotherapy. Owing to current gaps in knowledge, autologous stem cell transplantation for this disease should only be used within controlled trials at present…

View original post here: 
Autologous Stem Cell Transplantation For Soft Tissue Sarcoma: Insufficient Research Into Therapy

Related posts:

1. NICE Draft Guidance Recommends New Treatment Option For Advanced Soft Tissue Sarcoma A new treatment which could extend the lives of a specific group of cancer patients will be available on the NHS. In the final draft of guidance published today (21...
2. Advanced Leukemia Successfully Treated With First Use Of Antibody And Stem Cell Transplantation For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell...
3. Effects Of Intranodal Autologous Tumor Lysate-DC Vaccine With Aldesleukin (IL-2) And IFN-alpha2a In Metastatic Renal Cell Carcinoma Patients UroToday.com - Immunotherapy with interleukin 2 (IL-2) for metastatic renal cancer continues to offer a minority of patients the potential of durable complete responses without additional treatments. The lack of...
4. Bioheart Makes Breakthrough In Critical Limb Ischemia Therapy With Stem Cells Obtained From Fat Tissue Bioheart, Inc. (OTC Bulletin Board: BHRT) offers yet another medical breakthrough with the next-level stem cell treatment for critical limb ischemia patients. The stem cells aid in promoting angiogenesis or...
5. ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data At Annual Meeting Of The Connective Tissue Oncology Society ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) presented today at the 15th Annual Connective Tissue Oncology Society (CTOS) Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM,...
6. Islet Cell Transplantation In Scotland The Scottish National Blood Transfusion Service has opened a new laboratory in Edinburgh to offer around 12 people a year islet cell transplant therapy. Islet cell transplant therapy is a...
7. $11 Million NIH Grant For Stem Cell Research Awarded To Rhode Island Hospital Rhode Island Hospital has received an $11 million grant to fund research that will lead to a general understanding of stem cell biology and identify unique approaches to tissue regeneration...
8. New Ethical Questions Are Being Raised In Stem Cell Research A groundbreaking discovery two years ago that turned ordinary skin cells back into an embryonic or "pluripotent" state was hailed as the solution to the controversial ethical question that has...
9. Transplantation Of Stem Cells Alleviates Side Effects Of Radiotherapy In Rats Human embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study. Research with rats found that transplanted...
10. Using Embryonic Stem Cell Therapy, Walking Ability Restored In Rats With Neck Injuries The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a...
11. Scientists Reveal How Induced Pluripotent Stem Cells Differ From Embryonic Stem Cells And Tissue Of Derivation The same genes that are chemically altered during normal cell differentiation, as well as when normal cells become cancer cells, are also changed in stem cells that scientists derive from...
12. Marking Of Tissue-Specific Crucial In Embryonic Stem Cells To Ensure Proper Function Tissue-specific genes, thought to be dormant or not marked for activation in embryonic stem cells, are indeed marked by transcription factors, with proper marking potentially crucial for the function of...
13. CytRx Announces Plan To Initiate A Phase 2 Clinical Trial With INNO-206 In Patients With Advanced Soft Tissue Sarcomas CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company, today announced plans to initiate a multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a treatment for patients with advanced...
14. Univ. Of Nebraska Board Of Regents Votes To Maintain Current Embryonic Stem Cell Policy The University of Nebraska Board of Regents last week voted 4-4 not to restrict embryonic stem cell research policy beyond current federal and state limits, the New York Times reports....
15. NIH Approves New Stem Cell Lines For Research The National Institutes of Health announced approval of embryonic stem cell lines for federally funded research. The Washington Post reports the decision is "opening the way for millions of taxpayer...

« Discover How Water Should Taste With Water Filtration Systems Christian Dior – Make Up and Fashion Chic »